Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Worm

Showing results (41-50 of 104) with videos related to

Pageof 11
Sort By:
Ugeskrift for Laeger|October 27, 1986
[Diagnosis and therapeutic control of gonorrhea. Effects and costs]A M Worm, H Fogh, C S Petersen
Scandinavian Journal of Haematology|April 1, 1977
Blastic transformation of chronic myelocytic leukaemia. Clinical manifestations, prognostic factors and results of therapyJ Pedersen-Bjergaard, A M Worm, B Hainau
Danish Medical Bulletin|October 1, 1985
Erythromycin against Chlamydia trachomatis infections. A double blind study comparing 4- and 7-day treatment in men and womenA M Worm, C Avnstorp, C S Petersen
Scandinavian Journal of Infectious Diseases|January 1, 1993
Risk factors for hepatitis B virus infection in heterosexuals attending a venereal disease clinic in CopenhagenB B Kvinesdal, A M Worm, A Gottschau
Acta Dermato-Venereologica|January 1, 1984
Activation of complement in the skin after PUVA therapyO J Clemmensen, B Staberg, A M Worm
Lancet (London, England)|June 30, 1984
The cost of hepatitis B vaccineC S Petersen, A M Worm, S Kroon
Ugeskrift for Laeger|June 25, 1984
[WR--still an current blood test]S Helqvist, C S Petersen, A M Worm
Genitourinary Medicine|August 1, 1985
Erythromycin for four or seven days against Chlamydia trachomatisA M Worm, C Avnstorp, C S Petersen
The British Journal of Dermatology|November 1, 1976
Plasma volume, intravascular albumin and its transcapillary escape rate in patients with extensive skin diseaseH H Parving, A M Worm, N Rossing
Ugeskrift for Laeger|May 20, 1985
[Simultaneous occurrence of Trichomonas vaginalis and gonorrhea in women]O Knudsen, L H Larsen, A M Worm
Pageof 11

Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Ugeskrift for Laeger|October 27, 1986
[Diagnosis and therapeutic control of gonorrhea. Effects and costs]A M Worm, H Fogh, C S Petersen
Scandinavian Journal of Haematology|April 1, 1977
Blastic transformation of chronic myelocytic leukaemia. Clinical manifestations, prognostic factors and results of therapyJ Pedersen-Bjergaard, A M Worm, B Hainau
Danish Medical Bulletin|October 1, 1985
Erythromycin against Chlamydia trachomatis infections. A double blind study comparing 4- and 7-day treatment in men and womenA M Worm, C Avnstorp, C S Petersen
Scandinavian Journal of Infectious Diseases|January 1, 1993
Risk factors for hepatitis B virus infection in heterosexuals attending a venereal disease clinic in CopenhagenB B Kvinesdal, A M Worm, A Gottschau
Acta Dermato-Venereologica|January 1, 1984
Activation of complement in the skin after PUVA therapyO J Clemmensen, B Staberg, A M Worm
Lancet (London, England)|June 30, 1984
The cost of hepatitis B vaccineC S Petersen, A M Worm, S Kroon
Ugeskrift for Laeger|June 25, 1984
[WR--still an current blood test]S Helqvist, C S Petersen, A M Worm
Genitourinary Medicine|August 1, 1985
Erythromycin for four or seven days against Chlamydia trachomatisA M Worm, C Avnstorp, C S Petersen
The British Journal of Dermatology|November 1, 1976
Plasma volume, intravascular albumin and its transcapillary escape rate in patients with extensive skin diseaseH H Parving, A M Worm, N Rossing
Ugeskrift for Laeger|May 20, 1985
[Simultaneous occurrence of Trichomonas vaginalis and gonorrhea in women]O Knudsen, L H Larsen, A M Worm
Pageof 11